SkylineDX’s test stratifies cutaneous melanoma patients into metastatic risk categories to inform treatment decisions.
Traditional testing, though valuable, is often reactive and identifies quality issues only after they have occurred. This can lead to project delays and financial and reputational losses. In fact, ...
Researchers from University of California San Diego School of Medicine have found that testing for lipoprotein(a)—a genetic risk factor for heart disease—remains uncommon in the United States, despite ...
NEW YORK--(BUSINESS WIRE)--Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis™ Breast CTX, a new predictive capability ...
Prostate cancer is the second leading cause of cancer death in men in the U.S., with an expected 288,000 cases and 34,700 deaths expected in 2023, per the American Cancer Society. As artificial ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial An increasing number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results